Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM

NCT03452579 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Nivolumab
DRUG: Standard Dose Bevacizumab
DRUG: Low Dose Bevacizumab

Sponsor

David Peereboom